Team Innate immune system in infection, inflammation and cancer
Our team studies the innate immune system in acute and chronic inflammatory diseases in children and adults.
The team’s focus
In our team, we integrate various advanced experimental approaches to investigate disease-specific subpopulations of myeloid cells in blood and tissues from patients and healthy individuals. Currently, the team focuses on characterizing the granulocyte subpopulations in psoriasis, Langerhans cell histiocytosis and in viral infections and understand how the granulocytes communicate with other cells contributing to disease pathology. Our goal is to improve the diagnosis and treatment of patients.
Team leader
Magdalini Lourda
Senior Research SpecialistCurrent projects
- Granulocyte phenotype and function in guttate and plaque psoriasis, in Langerhans cell histiocytosis (LCH) and in COVID-19.
- In-depth characterization of disease mechanisms in LCH.
Our research in media
News articles
Innate immune response may predict COVID-19 severity
Blodprov kan förutspå hur sjuk du blir i covid-19 (only in Swedish)
Main collaborators
LCH
Jan-Inge Henter, MD-PhD. Karolinska Institute and Karolinska University Hospital, Stockholm
Tatiana von Bahr Greenwood, MD-PhD. Karolinska Institute and Karolinska University Hospital, Stockholm
Daniel Hagey, PhD. Karolinska Institute, Stockholm
Martin Jädersten, MD-PhD. Karolinska Institute and Karolinska University Hospital, Stockholm
Psoriasis
Josefin Lysell, MD-PhD. Karolinska Institute and Karolinska University Hospital, Stockholm
Avinash Padhi, PhD. Karolinska Institute, Stockholm
Liv Eidsmo, MD-PhD. Karolinska Institute, Stockholm and LEO Foundation Skin Immunology Research Center, Copenhagen
Peter Bergman, MD-PhD. Karolinska Institute and Karolinska University Hospital, Stockholm
COVID-19, inflammatory bowel disease, sepsis, tuberculosis
Petter Höglund, MD-PhD. Karolinska Institute and Karolinska University Hospital, Stockholm
Mattias Svensson, PhD. Karolinska Institute, Stockholm
Anna Norrby-Teglund, PhD. Karolinska Institute, Stockholm
Susanna Brighenti, PhD. Karolinska Institute, Stockholm
Henrik Arnell, MD-PhD. Karolinska Institute and Karolinska University Hospital, Stockholm
Research funding
- The Swedish Childhood Cancer Fund
- Dr Åke Olsson foundation for haematological research
- Fredrik O Ingrid Thurings foundation
- Märta and Gunnar V Philipsons foundation
- Karolinska Institute Foundations & Donations
- Karolinska Institute Doctoral funding
Open positions
We always want to get in touch with talented potential co-workers. If you are interested in doing research in our team, either as a student or post-doc, please contact the Team leader at: magdalini.lourda@ki.se.
Previous team members
- David Fusté Vegas, Bachelor student. Erasmus+ traineeship.
- Lara Antonia Kaland Thielcke, Bachelor student. Research assistant.
- Avinash Padhi, PhD. Postdoc.
- Mira Akber, MSc. Research trainee/research assistant.
Selected publications
Intestinal stroma guides monocyte differentiation to macrophages through GM-CSF.
Kvedaraite E, Lourda M, Mouratidou N, Düking T, Padhi A, Moll K, Czarnewski P, Sinha I, Xagoraris I, Kokkinou E, Damdimopoulos A, Weigel W, Hartwig O, Santos TE, Soini T, Van Acker A, Rahkonen N, Flodström Tullberg M, Ringqvist E, Buggert M, Jorns C, Lindforss U, Nordenvall C, Stamper CT, Unnersjö-Jess D, Akber M, Nadisauskaite R, Jansson J, Vandamme N, Sorini C, Grundeken ME, Rolandsdotter H, Rassidakis G, Villablanca EJ, Ideström M, Eulitz S, Arnell H, Mjösberg J, Henter JI, Svensson M
Nat Commun 2024 Feb;15(1):1752
Myeloid cells from Langerhans cell histiocytosis patients exhibit increased vesicle trafficking and an altered secretome capable of activating NK cells.
Hagey DW, Kvedaraite E, Akber M, Görgens A, Javadi J, Von Bahr Greenwood T, Björklund C, Åkefeldt SO, Hannegård-Hamrin T, Arnell H, Dobra K, Herold N, Svensson M, El Andaloussi S, Henter JI, Lourda M
Haematologica 2023 Sep;108(9):2422-2434
Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity.
Ambikan AT, Yang H, Krishnan S, Svensson Akusjärvi S, Gupta S, Lourda M, Sperk M, Arif M, Zhang C, Nordqvist H, Ponnan SM, Sönnerborg A, Treutiger CJ, O'Mahony L, Mardinoglu A, Benfeitas R, Neogi U
Cell Syst 2022 Aug;13(8):665-681.e4
Screening for neurodegeneration in Langerhans cell histiocytosis with neurofilament light in plasma.
Sveijer M, von Bahr Greenwood T, Jädersten M, Kvedaraite E, Zetterberg H, Blennow K, Lourda M, Gavhed D, Henter JI
Br J Haematol 2022 Aug;198(4):721-728
High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19.
Lourda M, Dzidic M, Hertwig L, Bergsten H, Palma Medina LM, Sinha I, Kvedaraite E, Chen P, Muvva JR, Gorin JB, Cornillet M, Emgård J, Moll K, García M, Maleki KT, Klingström J, Michaëlsson J, Flodström-Tullberg M, Brighenti S, Buggert M, Mjösberg J, Malmberg KJ, Sandberg JK, Henter JI, Folkesson E, Gredmark-Russ S, Sönnerborg A, Eriksson LI, Rooyackers O, Aleman S, Strålin K, Ljunggren HG, Björkström NK, Svensson M, Ponzetta A, Norrby-Teglund A, Chambers BJ,
Proc Natl Acad Sci U S A 2021 Oct;118(40):
High prevalence of peripheral lymphopenia in Langerhans cell histiocytosis.
Lourda M, Widesköld S, Kvedaraite E, Gavhed D, Akber M, von Bahr Greenwood T, Svensson M, Olsson-Åkefeldt S, Henter JI
Br J Haematol 2020 Oct;191(1):115-119
Tissue-infiltrating neutrophils represent the main source of IL-23 in the colon of patients with IBD.
Kvedaraite E, Lourda M, Ideström M, Chen P, Olsson-Åkefeldt S, Forkel M, Gavhed D, Lindforss U, Mjösberg J, Henter JI, Svensson M
Gut 2016 Oct;65(10):1632-41
Adsorptive depletion of blood monocytes reduces the levels of circulating interleukin-17A in Langerhans cell histiocytosis.
Lourda M, Olsson-Åkefeldt S, Gavhed D, Axdorph Nygell U, Berlin G, Laurencikas E, von Bahr Greenwood T, Svensson M, Henter JI
Blood 2016 Sep;128(9):1302-5